CXCR2 and neoplasm: In addition to IL-8, migration inhibitory factor (MIF) from tumor cells induces CXCR2-dependent chemotaxis, improved neutrophil survival, and release of CCL4 and MMP-9, helping develop aggressive HNSCC phenotype [220].